BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 721465)

  • 21. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 22. BCG in cancer therapy: patient responses to BCG therapy for malignant melanoma.
    Sullivan BP
    Am J Nurs; 1979 Feb; 79(2):320-4. PubMed ID: 254539
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM; Hirshaut Y; Oettgen HF
    Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
    Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
    Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response and non-specific immunotherapy in melanoma.
    El-Domeiri AA
    Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)].
    Rundenstam CM
    Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E
    Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
    Spitler LE; Wong P; Sagebiel R
    Arch Dermatol; 1978 Oct; 114(10):1501-4. PubMed ID: 718187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unspecific, active BCG vaccination therapy in melanoma using a modified scarification procedure].
    Wolf M; Menzel W; Keller G
    Dermatol Monatsschr; 1978 Apr; 164(4):302-3. PubMed ID: 668966
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of malignant melanoma.
    Rosenberg SA
    Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
    Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
    [No Abstract]   [Full Text] [Related]  

  • 35. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas].
    Richter J; Duchková H; Kubíková M
    Cas Lek Cesk; 1975 Sep; 114(39):1201-3. PubMed ID: 1182748
    [No Abstract]   [Full Text] [Related]  

  • 36. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
    Coates AS; Peters M
    Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunotherapy of melanoma (proceedings)].
    Bolund C
    Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with immune BCG therapy of malignant melanoma].
    Altmeyer P; Nödl F
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibilities of nonspecific immunotherapy with BCG in malignant melanomas of the skin].
    Romano S; Ziccardi M; Muzio GF; Filippi B
    Arch Maragliano Patol Clin; 1976; 32():114-21. PubMed ID: 802769
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of immunotherapy in malignant melanoma].
    Lewis MG
    Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.